Surgery Partners, Inc. (SGRY) Dividend History

Surgery Partners, Inc. (SGRY) is a healthcare company that provides outpatient surgical services through a network of surgical facilities across the United States. The company focuses on delivering specialized procedures in areas such as outpatient surgery, endoscopy, pain management, and other ambulatory care services, aiming to improve patient outcomes and streamline healthcare delivery.

310 Seven Springs Way, Brentwood, TN, 37027
Phone: 615-234-5900
Website:

Dividend History

Surgery Partners, Inc. currently does not pay dividends

Company News

  • Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital

    Surgery Partners, Inc. has received a non-binding acquisition proposal from Bain Capital to acquire all outstanding shares not already owned by Bain Capital for $25.75 per share. A special committee of independent directors will consider the proposal with the assistance of advisors.

    Benzinga
  • After-hours movers: Netflix, Intuitive Surgical, and more By Investing.com - Investing.com Canada

    Netflix reported mixed Q2 results, with better-than-expected earnings but weaker guidance. Intuitive Surgical saw strong Q2 results, with a 17% increase in procedures. Plug Power announced a $200 million stock offering, while Surgery Partners is exploring strategic options including a potential sale.

    Investing.com
    Featured Companies: ISRG NFLX PLUG
  • Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know

    In the latest quarter, 4 analysts provided ratings for Surgery Partners (NASDAQ:SGRY), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Surgery Partners, presenting an average target of $40.5, a high estimate of $50.00, and a low estimate of $31.00. Observing a downward trend, the current average is 11.96% lower than the prior average price target of $46.00. Diving into Analyst Ratings: An In-Depth Exploration The standing of Surgery Partners among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Tao Qiu Macquarie Announces Outperform $31.00 - Jason Cassorla Citigroup Lowers Buy $38.00 $42.00 Bill Sutherland Benchmark Maintains Buy $50.00 $50.00 Sarah James Cantor Fitzgerald Maintains Overweight $43.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Surgery ...Full story available on Benzinga.com

    Benzinga
  • Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock?

    Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

    Zacks Investment Research
    Featured Companies: TDOC
  • Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates

    Surgery Partners (SGRY) delivered earnings and revenue surprises of 42.86% and 1.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: EHAB

Related Companies

Dividend data last updated 06/07/2025 01:02:12 UTC